XPENG INC - ADR
XPEVNYSE🏆 #700 by market capEarnings Aug 24US Equity
$123.85▲ $2.11 (+1.70%)
Simulated price1h—
24h▲ 1.7%
7d—
14d—
30d—
1y—
🏦Market Cap
$11.29B
Mid Cap
📈Revenue Growth (YoY)
+82.6%
High Growth
📊Gross Margin
19.9%
Thin
💵FCF Margin
—
⚖️P/S Ratio
1.0x
Cheap
Otter Score
57
Weak
📊
Analyst Ratings
Price
$123.85
Total
17
Raised
7
Lowered
3
Avg PT
$19.73
H / L
$25 / $15
| Institution | Action | Rating | Date |
|---|---|---|---|
Barclays | Reiterated | Underweight | 2026-07-16 |
Macquarie | Upgraded | Neutral → Outperform | 2026-05-29 |
Freedom Broker | Upgraded | Hold → Buy | 2026-01-06 |
Freedom Capital Markets | Upgraded | Hold → Buy | 2026-01-06 |
Citigroup | Reiterated | Buy | 2025-08-20 |
B of A Securities | Reiterated | Buy | 2025-08-19 |
JP Morgan | Reiterated | Overweight | 2025-03-19 |
UBS | Upgraded | Sell → Neutral | 2025-02-24 |
China Renaissance | Upgraded | Hold → Buy | 2024-11-22 |
Bernstein | Reiterated | Market Perform | 2024-11-20 |
Morgan Stanley | Reiterated | Overweight | 2024-03-11 |
CLSA | Reiterated | Outperform → Buy | 2023-08-08 |
HSBC | Upgraded | Hold → Buy | 2023-08-07 |
Jefferies | Upgraded | Hold → Buy | 2023-07-28 |
BOCOM International | Downgraded | Neutral → Sell | 2023-07-07 |
Daiwa Capital | Downgraded | Buy → Sell | 2022-12-14 |
Nomura Instinet | Downgraded | Buy → Neutral | 2022-07-01 |
One row per institution, most recent rating